Effective November 20, 2009, Camelot Corp. announced that Danny Wettreich resigned as President, Chief Executive Officer, Chairman and Treasurer of the Company and elected Mr. Jeffrey Rochlin as President, Chief Executive Officer, Chairman and Treasurer of the Company. Mr. Rochlin, 40, is a resident of Washington Township, NJ, and a graduate of University of Hartford, where he earned a degree in accounting. His professional experience has been primarily in the finance sector, where he has worked as a finance manager in operations, and senior accountant for a major pharmaceutical company. Currently, he works for a biotechnology company in its budgeting and financial reporting sector. The company also changed the location of its principal executive offices from 18170 Hillcrest, Suite 100, Dallas, TX 75252 to 730 W. Randolph Street, Suite 600, Chicago, IL 60661 and its telephone number from 972-612-1400 to 312-454-0015.

Camelot Corp. reported earnings results for the first quarter ended July 31, 2009. For the quarter, the company reported net loss of $1,810, up $3,143 for the same quarter the previous year.

Camelot Corp. filed its 10-K on July 02, 2009 for the period ending April 30, 2009. In this report its auditor, Comiskey & Company, gave an unqualified opinion expressing doubt that the company can continue as a going concern.